Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P130008/S144

INSPIRE II UPPER AIRWAY STIMULATOR

Inspire Medical Systems · Decision date Oct 26, 2026

MEDTECHLEDGER EXPLANATIONP130008/S144

What did the FDA approve?

FDA supplement P130008/S144, dated 2026-10-26, records an approval for a minor software update to the Model 2740S SleepSync Programmer Application. The stated purpose is to address known software bugs, improve user experience, and perform code maintenance, including updates to software of unknown provenance (SOUP). The supplement type is Real-Time Process, and the reason is Change Design/Components/Specifications/Material.

This supplement does not represent a new approval of the INSPIRE II Upper Airway Stimulator system. The record identifies the device as a Stimulator, hypoglossal nerve, implanted, apnea under product code MNQ, with the applicant Inspire Medical Systems. The source statement reports the intended scope of the software change but does not provide independent proof of safety or clinical effectiveness for the updated programmer application.

FDA approval order statement

approval for a minor software update to the Model 2740S SleepSync Programmer Application to address known software bugs, improve user experience, and perform code maintenance which includes updates to software of unknown provenance (SOUP).
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Anesthesiology
Decision date
Oct 26, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P130008/S144
Regulatory pathway
PMA supplement
Product code
MNQ
Decision code
APPR
Decision date
Oct 26, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, hypoglossal nerve, implanted, apnea.

Product code
MNQ
FDA device class
3

For the original device and its historical approval scope, see PMA P130008. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P130008 · Original PMA

    INSPIRE II UPPER AIRWAY STIMULATOR

  2. P130008/S144 received

    Application receipt date recorded by FDA.

  3. P130008/S144 · FDA decision

    Real-Time Process

  4. P130008/S148 · Related supplement

    Model 4063 Dedicated Tray Sealer

Timeline entries are records held by MedtechLedger for P130008. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P130008

Product / regulatory recordCompanyPathwayDecision dateSource
Inspire Medical SystemsPMA approvalApr 30, 2014FDA
Model 3150 IPGP130008/S146
Inspire Medical SystemsPMA supplementOct 13, 2026FDA
Model 3150 IPGP130008/S147
Inspire Medical SystemsPMA supplementOct 22, 2026FDA
Inspire Medical SystemsPMA supplementNov 5, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Inspire Medical Systems

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
9700 63rd Ave. N., Suite 200, Maple Grove, MN, 55369

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records